Eli Lilly and Company (BVL:LLY)
Peru
· Delayed Price · Currency is PEN · Price in USD 1,096.00
0.00 (0.00%)
At close: Feb 26, 2026
Eli Lilly and Company Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 65,179 | 45,043 | 34,124 | 28,541 | 28,318 | Upgrade
|
| Revenue Growth (YoY) | 44.70% | 32.00% | 19.56% | 0.79% | 15.40% | Upgrade
|
| Cost of Revenue | 11,052 | 8,418 | 7,082 | 6,630 | 6,973 | Upgrade
|
| Gross Profit | 54,127 | 36,625 | 27,042 | 21,912 | 21,345 | Upgrade
|
| Selling, General & Admin | 11,094 | 8,594 | 7,404 | 6,068 | 6,142 | Upgrade
|
| Research & Development | 13,337 | 10,991 | 9,313 | 7,191 | 6,931 | Upgrade
|
| Operating Expenses | 24,431 | 19,585 | 16,717 | 13,258 | 13,073 | Upgrade
|
| Operating Income | 29,696 | 17,040 | 10,325 | 8,653 | 8,273 | Upgrade
|
| Interest Expense | - | - | - | -331.6 | -339.8 | Upgrade
|
| Interest & Investment Income | - | - | - | 62.8 | 25.4 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | -191.3 | -204.6 | Upgrade
|
| Other Non Operating Income (Expenses) | -571 | -219 | 97 | 177 | 256 | Upgrade
|
| EBT Excluding Unusual Items | 29,125 | 16,821 | 10,422 | 8,370 | 8,010 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -13 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -410.7 | 176.9 | Upgrade
|
| Asset Writedown | -484 | -861 | -68 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | -244.6 | -1,048 | Upgrade
|
| Pretax Income | 25,731 | 12,680 | 6,554 | 6,806 | 6,156 | Upgrade
|
| Income Tax Expense | 5,091 | 2,090 | 1,314 | 561.6 | 573.8 | Upgrade
|
| Earnings From Continuing Operations | 20,640 | 10,590 | 5,240 | 6,245 | 5,582 | Upgrade
|
| Net Income | 20,640 | 10,590 | 5,240 | 6,245 | 5,582 | Upgrade
|
| Net Income to Common | 20,640 | 10,590 | 5,240 | 6,245 | 5,582 | Upgrade
|
| Net Income Growth | 94.90% | 102.10% | -16.09% | 11.88% | -9.88% | Upgrade
|
| Shares Outstanding (Basic) | 897 | 901 | 900 | 902 | 907 | Upgrade
|
| Shares Outstanding (Diluted) | 899 | 904 | 903 | 905 | 912 | Upgrade
|
| Shares Change (YoY) | -0.53% | 0.09% | -0.15% | -0.78% | -0.09% | Upgrade
|
| EPS (Basic) | 23.00 | 11.76 | 5.82 | 6.93 | 6.15 | Upgrade
|
| EPS (Diluted) | 22.95 | 11.71 | 5.80 | 6.90 | 6.12 | Upgrade
|
| EPS Growth | 95.99% | 101.90% | -15.94% | 12.75% | -9.87% | Upgrade
|
| Free Cash Flow | 8,972 | 3,760 | 792 | 5,731 | 6,056 | Upgrade
|
| Free Cash Flow Per Share | 9.98 | 4.16 | 0.88 | 6.34 | 6.64 | Upgrade
|
| Dividend Per Share | 6.000 | 5.200 | 4.520 | 3.920 | 3.400 | Upgrade
|
| Dividend Growth | 15.38% | 15.04% | 15.31% | 15.29% | 14.87% | Upgrade
|
| Gross Margin | 83.04% | 81.31% | 79.25% | 76.77% | 75.38% | Upgrade
|
| Operating Margin | 45.56% | 37.83% | 30.26% | 30.32% | 29.21% | Upgrade
|
| Profit Margin | 31.67% | 23.51% | 15.36% | 21.88% | 19.71% | Upgrade
|
| Free Cash Flow Margin | 13.76% | 8.35% | 2.32% | 20.08% | 21.39% | Upgrade
|
| EBITDA | 31,693 | 18,807 | 11,852 | 10,176 | 9,820 | Upgrade
|
| EBITDA Margin | 48.63% | 41.75% | 34.73% | 35.65% | 34.68% | Upgrade
|
| D&A For EBITDA | 1,997 | 1,767 | 1,527 | 1,523 | 1,548 | Upgrade
|
| EBIT | 29,696 | 17,040 | 10,325 | 8,653 | 8,273 | Upgrade
|
| EBIT Margin | 45.56% | 37.83% | 30.26% | 30.32% | 29.21% | Upgrade
|
| Effective Tax Rate | 19.79% | 16.48% | 20.05% | 8.25% | 9.32% | Upgrade
|
| Advertising Expenses | - | - | - | 966.8 | 1,240 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.